Antigen-presenting innate lymphoid cells orchestrate neuroinflammation.
作者信息
Grigg John B, Shanmugavadivu Arthi, Regen Tommy, Parkhurst Christopher N, Ahmed Anees, Joseph Ann M, Mazzucco Michael, Gronke Konrad, Diefenbach Andreas, Eberl Gerard, Vartanian Timothy, Waisman Ari, Sonnenberg Gregory F
机构信息
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
出版信息
Nature. 2021 Dec;600(7890):707-712. doi: 10.1038/s41586-021-04136-4. Epub 2021 Dec 1.
Pro-inflammatory T cells in the central nervous system (CNS) are causally associated with multiple demyelinating and neurodegenerative diseases, but the pathways that control these responses remain unclear. Here we define a population of inflammatory group 3 innate lymphoid cells (ILC3s) that infiltrate the CNS in a mouse model of multiple sclerosis. These ILC3s are derived from the circulation, localize in proximity to infiltrating T cells in the CNS, function as antigen-presenting cells that restimulate myelin-specific T cells, and are increased in individuals with multiple sclerosis. Notably, antigen presentation by inflammatory ILC3s is required to promote T cell responses in the CNS and the development of multiple-sclerosis-like disease in mouse models. By contrast, conventional and tissue-resident ILC3s in the periphery do not appear to contribute to disease induction, but instead limit autoimmune T cell responses and prevent multiple-sclerosis-like disease when experimentally targeted to present myelin antigen. Collectively, our data define a population of inflammatory ILC3s that is essential for directly promoting T-cell-dependent neuroinflammation in the CNS and reveal the potential of harnessing peripheral tissue-resident ILC3s for the prevention of autoimmune disease.
相似文献
Zh Nevrol Psikhiatr Im S S Korsakova. 2022
引用本文的文献
J Neuroinflammation. 2025-6-23
J Neuroinflammation. 2025-4-24
Front Immunol. 2025-2-17
Proc Natl Acad Sci U S A. 2025-3-4
Pharmacol Res Perspect. 2025-4
Signal Transduct Target Ther. 2025-1-17
本文引用的文献
J Neuroinflammation. 2020-3-13
Nat Rev Immunol. 2019-7-26
J Exp Med. 2019-3-27